unknown
Stage
About
EVIIVE AG develops blood-based diagnostics that profile extracellular vesicles (EVs) using single-EV multi-omics to discover biomarkers and guide immuno-oncology treatment selection and companion diagnostics.
Explore EVIIVE AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.